b

BUPHTHALMOS

/ / 13 min read

Table of Contents

Buphthalmos: Definition and Historical Context

Buphthalmos, derived from the Greek terms meaning “ox eye,” is a significant ophthalmological condition defined by the abnormal and pathological enlargement of the entire globe of the eye. This enlargement occurs specifically when increased intraocular pressure (IOP) acts upon the scleral and corneal tissues before they have achieved structural rigidity, typically during infancy or early childhood. It is crucial to distinguish buphthalmos from simple megalocornea or macrocornea, conditions where only the cornea is enlarged without corresponding increases in axial length or significant elevation of IOP. Buphthalmos is not merely a cosmetic issue; it represents a primary clinical sign of uncontrolled congenital glaucoma (also known as infantile glaucoma or primary congenital glaucoma, PCG), a severe disease that threatens visual development and integrity. The recognition of buphthalmos demands immediate and aggressive intervention, as the underlying elevated pressure can swiftly lead to irreversible damage to the optic nerve head and subsequent blindness.

The pathophysiology underlying buphthalmos is directly linked to the elasticity of the infant eye. Unlike the adult eye, where prolonged high IOP leads primarily to cupping and atrophy of the optic nerve head (adult glaucoma), the pediatric eye wall stretches in response to pressure. This stretching results in an increase in the axial length, corneal diameter, and overall volume of the globe, giving the characteristic large appearance. Historically, the presence of buphthalmos was one of the earliest recognized signs of congenital ocular disease, compelling early physicians to study the dynamics of aqueous humor flow and the anatomical structures responsible for IOP regulation. Although the condition is relatively rare, its impact on visual acuity and development is profound, necessitating specialized pediatric ophthalmological care.

The definition of buphthalmos is generally established when the corneal diameter exceeds specific age-related norms, often greater than 12 millimeters (mm) in a newborn, or when a marked difference in size is noted between the two eyes (anisometropia). The condition is frequently bilateral, though often asymmetrical. The term “moon face,” sometimes colloquially used to describe the appearance associated with severe buphthalmos, refers to the prominent, often protruding appearance of the enlarged eyes within the orbital structure. The presence of buphthalmos confirms a prolonged period of elevated IOP acting on a malleable structure, confirming the diagnosis of primary congenital glaucoma unless proven otherwise by secondary causes such as trauma or specific syndromes. Therefore, the physical manifestation of buphthalmos serves as a critical warning sign that the visual apparatus is under destructive stress.

Etiology and Pathophysiology of Intraocular Pressure

The primary and most frequent cause of buphthalmos is Primary Congenital Glaucoma (PCG). PCG is an inherited developmental anomaly affecting the drainage angle of the eye, specifically the structures responsible for filtering the aqueous humor. In PCG, the developmental arrest or malformation often involves the angle of the anterior chamber, characterized by a membrane or immature tissue overlaying the trabecular meshwork and Schlemm’s canal. This anatomical defect prevents the normal outflow of aqueous humor, leading to its accumulation and a subsequent, sustained rise in intraocular pressure (IOP). Since the sclera and cornea of infants are highly extensible, this chronic elevation of IOP results in the progressive stretching and enlargement that defines buphthalmos. The mechanism is purely hydraulic: pressure exerted on elastic walls causes expansion.

The dynamics of aqueous humor production and drainage are central to understanding the etiology. Aqueous humor is constantly produced by the ciliary body and flows through the pupil into the anterior chamber. It must then drain through the trabecular meshwork into Schlemm’s canal and ultimately into the venous system. In PCG, the resistance to outflow in the anterior chamber angle is abnormally high. This mechanical obstruction elevates the hydrostatic pressure within the globe. The younger the infant, the more elastic the ocular tissues, meaning that even moderate pressure elevations can rapidly induce stretching. If buphthalmos develops rapidly, the acute stretching can also lead to rupture of the Descemet membrane, known as Haab’s striae, which appears clinically as curvilinear breaks on the posterior surface of the cornea. These breaks often contribute to temporary or permanent corneal edema and haziness.

While PCG accounts for the majority of buphthalmos cases, secondary causes must also be considered, particularly when the condition presents unilaterally or later in infancy. Secondary etiologies involve acquired conditions that impede aqueous outflow or increase its production.

  • Ocular Trauma: Injuries can cause angle recession or inflammation, damaging the trabecular meshwork and impairing drainage.
  • Inflammation and Infection (Uveitis): Chronic inflammation can lead to the formation of peripheral anterior synechiae (adhesions) that physically block the drainage angle.
  • Intraocular Tumors: Rarely, tumors like retinoblastoma can lead to secondary glaucoma by obstructing drainage or causing neovascularization in the angle.
  • Developmental Syndromes: Buphthalmos is a recognized feature of several systemic disorders, including Sturge-Weber syndrome (due to episcleral hemangioma causing elevated venous pressure), Neurofibromatosis Type 1 (NF1), and Axenfeld-Rieger syndrome (which involves inherent angle dysgenesis). In these cases, the glaucoma is syndromic rather than isolated PCG.

Clinical Manifestations and Associated Signs

The clinical presentation of buphthalmos involves a triad of classic symptoms, often observed by parents or pediatricians, known collectively as the “BIP triad”: Blepharospasm (excessive blinking or lid squeezing), Irritability/Photophobia (extreme sensitivity to light), and Epiphora (excessive tearing). These symptoms are typically the infant’s reaction to the discomfort caused by elevated IOP and the resulting corneal edema. The photophobia can be severe, causing the infant to consistently turn away from light or keep their eyes tightly closed. These early signs often precede the visual observation of globe enlargement, highlighting the importance of parental vigilance and early pediatric screening.

Physical signs of established buphthalmos are dramatic and readily observable during an ocular examination. The most obvious sign is the macro-globe appearance, characterized by an enlarged corneal diameter, often exceeding 13 mm in older infants. Concurrently, the cornea may appear hazy or cloudy due to stromal edema, which results from the high pressure overwhelming the endothelial pump function responsible for keeping the cornea clear. The presence of Haab’s striae is pathognomonic for buphthalmos; these fine, curved breaks in the Descemet membrane are caused by the rapid stretching of the globe wall and often run horizontally or concentrically near the limbus. While initially causing significant edema, these breaks may heal, leaving faint, permanent opacities.

Beyond the anterior segment changes, buphthalmos causes significant internal damage. The stretching of the sclera leads to increased axial length, resulting in severe myopia (nearsightedness), which, if asymmetrical, can lead to anisometropic amblyopia (lazy eye). The sustained IOP also inflicts damage upon the optic nerve head, causing progressive cupping and atrophy, similar to adult glaucoma, although the appearance can be atypical due to the stretching of the laminar cribrosa. Other complications include thinning of the scleral wall, which increases the risk of rupture from minor trauma, and damage to the ciliary body, potentially affecting aqueous production later in life. Prompt identification of these manifestations is critical, as the resulting visual impairment, particularly amblyopia, can become permanent if the elevated pressure is not normalized quickly during the critical period of visual development.

Diagnosis and Ocular Examination Techniques

The diagnosis of buphthalmos is primarily clinical, established through a thorough ocular examination, often requiring examination under anesthesia (EUA) in young, uncooperative infants to ensure accurate measurements. The EUA allows the ophthalmologist to overcome the infant’s natural resistance and blepharospasm. The diagnostic process focuses on confirming globe enlargement, measuring IOP, assessing the integrity of the anterior chamber angle, and evaluating the optic nerve head. Accurate documentation of all findings is essential for tracking disease progression and treatment effectiveness.

Key diagnostic procedures performed during EUA include:

  1. Corneal Diameter Measurement: This is perhaps the most defining metric. A specialized caliper is used to measure the horizontal visible iris diameter (HVID). Measurements exceeding 12 mm in a full-term neonate or 13 mm in a child under one year strongly suggest buphthalmos.
  2. Tonometry: Measuring the IOP is challenging in infants due to corneal edema and elasticity. Specialized tonometers (e.g., Perkins handheld applanation tonometer or Icare rebound tonometer) are preferred. Normal IOP in infants is lower than in adults (typically 10-14 mmHg); persistent readings above 18-20 mmHg are highly suspicious, especially when accompanied by other signs.
  3. Gonioscopy: This procedure uses a specialized contact lens to visualize the anterior chamber angle directly, confirming the presence of developmental abnormalities characteristic of PCG, such as a high insertion of the iris, abnormal trabecular meshwork appearance, or thick, opaque tissue covering the angle structures. This is vital for planning surgical intervention.
  4. Optic Disc Evaluation: The optic nerve head is examined for evidence of glaucomatous damage (cupping). While stretching of the globe can sometimes make classic cupping assessment difficult, documentation of the cup-to-disc ratio is essential for monitoring progressive nerve damage.

In addition to direct ocular examination, imaging techniques provide supplementary quantitative data. Ocular Ultrasound (A-scan) is used to measure the axial length of the globe. An axial length significantly exceeding the age-matched norm confirms the globe expansion associated with buphthalmos. Furthermore, Ultrasound Biomicroscopy (UBM) or Anterior Segment Optical Coherence Tomography (AS-OCT) can provide high-resolution images of the angle structures, aiding in the differentiation of PCG from secondary or syndromic glaucomas. Blood tests and genetic screening may also be initiated if a systemic syndrome is suspected, such as testing for chromosomal abnormalities or specific genetic mutations linked to anterior segment dysgenesis.

Management Strategies: Medical and Surgical Interventions

The primary therapeutic goal in managing buphthalmos is the rapid and sustained reduction of intraocular pressure (IOP) to prevent further stretching of the globe and, critically, to halt damage to the optic nerve. Due to the anatomical obstruction inherent in PCG, medical therapy alone is rarely curative, and surgical intervention is the cornerstone of treatment. Medical management is typically employed as a temporary measure to stabilize IOP before surgery or as an adjunct therapy post-operatively.

Medical management involves the use of ocular hypotensive agents, though usage in infants must be approached cautiously due to potential systemic side effects.

  • Beta-blockers (e.g., Timolol): Used to decrease aqueous humor production, though often avoided in neonates due to risks of bradycardia and respiratory distress.
  • Carbonic Anhydrase Inhibitors (CAIs, e.g., Dorzolamide or Acetazolamide): These medications reduce aqueous production. Systemic CAIs (Acetazolamide) are highly effective but carry risks of metabolic acidosis and electrolyte imbalance, requiring careful monitoring.
  • Prostaglandin Analogs: Generally less favored in PCG as their efficacy relies on uveoscleral outflow, which may be less significant in infants, and their long-term ocular surface effects are a concern in young children.

Surgical management aims to directly address the underlying drainage obstruction. The choice of procedure depends on the clarity of the cornea and the surgeon’s preference.

  1. Goniotomy: This procedure involves surgically incising the abnormal tissue obstructing the trabecular meshwork under direct visualization. It is the preferred initial surgery if the cornea is sufficiently clear to allow visualization of the angle structures. Goniotomy works by creating an open pathway for aqueous humor directly into Schlemm’s canal.
  2. Trabeculotomy: When corneal haze obscures the view, making goniotomy impossible, trabeculotomy is performed. This procedure involves accessing Schlemm’s canal externally (through a scleral flap) and using a probe (trabeculotome) to break through the trabecular meshwork from within the canal, achieving the same drainage goal as goniotomy but via a different approach.
  3. Trabeculectomy and Drainage Devices: If primary angle surgeries (goniotomy or trabeculotomy) fail, or in cases of secondary glaucoma with complex mechanisms, filtration surgery (trabeculectomy) or the implantation of aqueous shunt devices (e.g., Ahmed or Baerveldt valves) may be necessary to create a new, bypass drainage route for the aqueous humor. These procedures are typically reserved for refractory cases due to the higher risk of complications.

Prognosis and Potential Complications

The prognosis for visual outcome in buphthalmos is highly dependent on the timing of diagnosis and intervention, the severity of the initial IOP elevation, and the extent of pre-existing optic nerve damage and globe stretching. If the condition is diagnosed and successfully treated early—ideally before significant corneal edema or optic nerve cupping occurs—the prognosis for preserving functional vision is generally good. Effective surgery can normalize IOP, halt the progression of buphthalmos, and allow for rehabilitation of the cornea and management of associated refractive errors. However, lifelong monitoring is mandatory, as PCG often requires multiple procedures and IOP can fluctuate significantly over time.

Despite successful surgical control of IOP, several potential complications often limit the final visual outcome. The irreversible stretching of the globe leads to permanent high axial myopia and often severe astigmatism. These significant refractive errors necessitate aggressive correction via glasses or contact lenses. Furthermore, if the visual axis was obstructed by corneal haze during the critical period of visual development, amblyopia (lazy eye) is a common sequela. Treating amblyopia through patching or pharmacological penalization is as important as controlling the IOP itself. Failure to manage amblyopia post-operatively can render the surgical success moot in terms of functional vision.

If buphthalmos is left untreated or inadequately managed, the prognosis is extremely poor, usually resulting in permanent blindness. Chronic, uncontrolled high IOP causes progressive optic nerve atrophy. The continuous stretching also risks complications such as corneal decompensation, where persistent edema leads to permanent opacification, and, in severe cases, scleral thinning and staphyloma formation, increasing the risk of globe rupture. Even after successful IOP control, patients require continuous comprehensive care, including regular IOP checks, visual acuity testing, refractive error management, and amblyopia treatment, often continuing into adulthood to manage the inherent risks associated with a stretched, structurally compromised globe.

Conclusion

Buphthalmos represents a pathological enlargement of the eyeball caused overwhelmingly by uncontrolled intraocular pressure (IOP) acting on the pliable ocular tissues of an infant. It serves as the hallmark clinical manifestation of Primary Congenital Glaucoma (PCG), a condition characterized by developmental abnormalities in the aqueous humor drainage system. Early recognition, often prompted by symptoms like photophobia, epiphora, and observable globe enlargement (corneal diameter > 12 mm), is paramount, as the condition progresses rapidly and threatens permanent vision loss.

Diagnosis relies heavily on examination under anesthesia (EUA) to accurately measure IOP, corneal diameter, and assess the anterior chamber angle using gonioscopy. Management is fundamentally surgical, utilizing procedures such as goniotomy or trabeculotomy to restore aqueous outflow. While surgical success in controlling IOP is achievable, the long-term prognosis is complicated by secondary issues, including severe myopia, astigmatism, and the pervasive risk of amblyopia. Therefore, effective management requires a multidisciplinary approach encompassing immediate surgical intervention followed by intensive optical correction and long-term visual rehabilitation to maximize the functional outcome for the affected child.

References

  • American Academy of Ophthalmology. (2021). Glaucoma. Retrieved from https://www.aao.org/eye-health/diseases/what-is-glaucoma

  • Hettinger, A. (2023). What is buphthalmos? Retrieved from https://www.verywellhealth.com/what-is-buphthalmos-3422072

  • Lam, D. (2021). What is buphthalmos? Retrieved from https://www.webmd.com/eye-health/buphthalmos#1

  • Kanski, J. J., & Bowling, B. (2020). Clinical Ophthalmology: A Systematic Approach (9th ed.). Elsevier. (Source used for expansion on pathophysiology and surgical details)

  • Shields, M. B. (2018). Textbook of Glaucoma (6th ed.). Wolters Kluwer. (Source used for expansion on diagnosis and management strategies)